Marvell Technology Group Ltd. |
|||||||||||||||
Condensed Consolidated Statements of Cash Flows (Unaudited) |
|||||||||||||||
(In thousands) |
|||||||||||||||
Three Months Ended |
Six Months Ended |
||||||||||||||
August 4,
|
July 29,
|
August 4,
|
July 29,
|
||||||||||||
Cash flows from operating activities: |
|||||||||||||||
Net income |
$ |
6,759 |
$ |
165,259 |
$ |
135,371 |
$ |
271,880 |
|||||||
Adjustments to reconcile net income to net cash provided by operating activities: |
|||||||||||||||
Depreciation and amortization |
26,754 |
20,444 |
47,097 |
41,186 |
|||||||||||
Share-based compensation |
59,392 |
22,422 |
83,244 |
46,439 |
|||||||||||
Amortization and write-off of acquired intangible assets |
25,939 |
1,065 |
25,939 |
2,136 |
|||||||||||
Amortization of inventory fair value adjustment associated with acquisition of Cavium |
22,933 |
— |
22,933 |
— |
|||||||||||
Amortization of deferred debt issuance costs and debt discounts |
7,073 |
— |
7,073 |
— |
|||||||||||
Restructuring related impairment charges (gain) |
1,993 |
70 |
1,993 |
(446) |
|||||||||||
Gain from investment in privately-held company |
— |
(750) |
(1,100) |
(750) |
|||||||||||
Amortization of premium /discount on available-for-sale securities |
(537) |
597 |
624 |
803 |
|||||||||||
Other non-cash expense (income), net |
3,414 |
(1,398) |
4,227 |
(1,423) |
|||||||||||
Deferred income taxes |
(22,238) |
2,008 |
(21,414) |
2,791 |
|||||||||||
Gain on sale of property and equipment |
(137) |
(341) |
(120) |
(283) |
|||||||||||
Gain on sale of discontinued operations |
— |
(34,032) |
— |
(42,187) |
|||||||||||
Gain on sale of business |
— |
(5,254) |
— |
(5,254) |
|||||||||||
Changes in assets and liabilities: |
|||||||||||||||
Accounts receivable |
(1,356) |
(14,550) |
(48,749) |
(36,313) |
|||||||||||
Inventories |
4,186 |
(3,170) |
6,866 |
(14,712) |
|||||||||||
Prepaid expenses and other assets |
(5,396) |
2,460 |
(19,504) |
7,854 |
|||||||||||
Accounts payable |
(15,015) |
(27,455) |
(271) |
3,968 |
|||||||||||
Accrued liabilities and other non-current liabilities |
(32,468) |
(21,793) |
(11,232) |
(33,418) |
|||||||||||
Accrued employee compensation |
(19,429) |
(846) |
(41,539) |
(8,375) |
|||||||||||
Deferred income |
68 |
(3,732) |
(729) |
1,284 |
|||||||||||
Net cash provided by operating activities |
61,935 |
101,004 |
190,709 |
235,180 |
|||||||||||
Cash flows from investing activities: |
|||||||||||||||
Purchases of available-for-sale securities |
(1,499) |
(177,811) |
(14,956) |
(376,227) |
|||||||||||
Sales of available-for-sale securities |
553,623 |
37,936 |
623,896 |
116,700 |
|||||||||||
Maturities of available-for-sale securities |
59,165 |
87,377 |
187,985 |
169,612 |
|||||||||||
Return of investment from privately-held companies |
— |
2,388 |
— |
2,388 |
|||||||||||
Purchases of time deposits |
— |
(75,000) |
(25,000) |
(150,000) |
|||||||||||
Maturities of time deposits |
75,000 |
75,000 |
150,000 |
150,000 |
|||||||||||
Purchases of technology licenses |
(903) |
(608) |
(1,263) |
(1,701) |
|||||||||||
Purchases of property and equipment |
(20,801) |
(4,803) |
(34,389) |
(14,544) |
|||||||||||
Proceeds from sales of property and equipment |
212 |
1,054 |
223 |
1,739 |
|||||||||||
Cash payment for acquisition of Cavium, net of cash and cash equivalents acquired |
(2,649,465) |
— |
(2,649,465) |
— |
|||||||||||
Net proceeds from sale of discontinued operations |
— |
41,976 |
— |
72,205 |
|||||||||||
Net proceeds from sale of business |
1,250 |
— |
1,250 |
— |
|||||||||||
Other |
— |
— |
(5,000) |
— |
|||||||||||
Net cash used in investing activities |
(1,983,418) |
(12,491) |
(1,766,719) |
(29,828) |
|||||||||||
Cash flows from financing activities: |
|||||||||||||||
Repurchases of common stock |
— |
(221,265) |
— |
(387,558) |
|||||||||||
Proceeds from employee stock plans |
33,525 |
77,872 |
44,580 |
97,811 |
|||||||||||
Minimum tax withholding paid on behalf of employees for net share settlement |
(12,883) |
(3,005) |
(36,776) |
(24,814) |
|||||||||||
Dividend payments to shareholders |
(39,383) |
(30,095) |
(69,181) |
(60,086) |
|||||||||||
Payments on technology license obligations |
(9,017) |
(7,481) |
(29,478) |
(14,296) |
|||||||||||
Proceeds from issuance of debt |
1,892,605 |
— |
1,892,605 |
— |
|||||||||||
Principal payments of debt |
(606,128) |
— |
(606,128) |
— |
|||||||||||
Payment of equity and debt financing costs |
(5,835) |
— |
(9,435) |
— |
|||||||||||
Net cash provided by (used in) financing activities |
1,252,884 |
(183,974) |
1,186,187 |
(388,943) |
|||||||||||
Net decrease in cash and cash equivalents |
(668,599) |
(95,461) |
(389,823) |
(183,591) |
|||||||||||
Cash and cash equivalents at beginning of period |
1,167,258 |
725,962 |
888,482 |
814,092 |
|||||||||||
Cash and cash equivalents at end of period |
$ |
498,659 |
$ |
630,501 |
$ |
498,659 |
$ |
630,501 |